Search results
7 lip 2018 · Although chronic respiratory failure can be supported rather effectively with NIV, acute episodes are much more difficult to manage. Generation of adequate cough is vital for mucus clearance during these acute episodes and is often significantly limited in patients with ALS.
23 mar 2018 · Death often results from respiratory failure within 3–5 years. Monitoring respiratory status is therefore critical to ALS management, as respiratory/pulmonary function tests (PFTs) are used to make decisions including when to initiate noninvasive ventilation.
Up to 95% of patients with ALS in the United States choose not to undergo tracheostomy; management of respiratory failure is therefore aimed at both prolonging survival as well as improving quality of life.
3 lis 2016 · Respiratory failure was the most common discharge diagnosis, occurring as primary code in 19.4 % and in any position in 31.6 % hospitalizations, followed by pneumonia (5.5 and 14.2 %, respectively) and aspiration pneumonia (1.0 and 2.1 %, respectively).
15 mar 2022 · Our study of early affected patients supports the use of a set of volitional and non-volitional respiratory tests to assess disease progression, rather than any single test. We found MVV a potentially useful marker of pulmonary function in ALS.
22 lut 2022 · Respiratory dysfunction is a common cause of morbidity and mortality in many neuromuscular disorders, but particularly important in motor neuron diseases (MND), such as amyotrophic lateral sclerosis (ALS) or spinal muscular atrophy (SMA).
Pulmonary Function Tests (PFTs) measure lung muscle strength and overall function. Lung function should be assessed at each clinic visit as part of an overall disease management strategy. Test results are used to determine the need for breathing assistance and supportive therapies. Each clinic visit gives you the
